Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival.

CONCLUSION: (90)Y microsphere radioembolization for chemorefractory colorectal liver metastases has an acceptable safety profile with a 50% estimated survival after 8.0 months. Pretreatment high bilirubin, alkaline phosphatase and tumor volume levels were associated with early death. PMID: 26625262 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26625262?dopt=Abstract

Source: Acta Oncologica - December 1, 2015 Category: Cancer & Oncology Authors: Maleux G, Deroose C, Laenen A, Verslype C, Heye S, Haustermans K, De Hertogh G, Sagaert X, Topal B, Aerts R, Prenen H, Vanbeckevoort D, Vandecaveye V, Van Cutsem E Tags: Acta Oncol Source Type: research